Sign in
4

Changes in Ownership

Mereo BioPharma Group plc Filed Acc 0000950170-25-009794

Options or other derivatives

  • Chief Scientific Officer acquired 116,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lewicki John A. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-25 Grant or award : show line 1 in the form Share Options (Right to buy) +116,000 116,000 D
Loading xslF345X05/ownership.xml…